Sulbactam sodium/Amoxicillin Sodium

舒巴坦钠/阿莫西林钠

Report date: 2024/01/18 15:18:20

Base Information

Drug NameSulbactam sodium/Amoxicillin Sodium
Drug Alias Name注射用阿莫西林钠舒巴坦钠
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsSkin Diseases, InfectiousRespiratory Tract Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Sulbactam sodiumAmoxicillin Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsSkin Diseases, InfectiousRespiratory Tract Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A